301 related articles for article (PubMed ID: 26650974)
1. Utilization of Psychopharmacological Treatment Among Patients With Newly Diagnosed Bipolar Disorder From 2001 to 2010.
Chang CM; Wu CS; Huang YW; Chau YL; Tsai HJ
J Clin Psychopharmacol; 2016 Feb; 36(1):32-44. PubMed ID: 26650974
[TBL] [Abstract][Full Text] [Related]
2. Psychotropic polypharmacy for the treatment of bipolar disorder in Taiwan.
Hung GC; Yang SY; Chen Y; Lin SK
Psychiatr Serv; 2014 Jan; 65(1):125-8. PubMed ID: 24382766
[TBL] [Abstract][Full Text] [Related]
3. Trends in treatment of newly treated schizophrenia-spectrum disorder patients in Taiwan from 1999 to 2006.
Wu CS; Lin YJ; Feng J
Pharmacoepidemiol Drug Saf; 2012 Sep; 21(9):989-96. PubMed ID: 22416032
[TBL] [Abstract][Full Text] [Related]
4. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
[TBL] [Abstract][Full Text] [Related]
5. Prescribing changes for bipolar patients discharged from two public psychiatric hospitals in Taiwan, 2006-2019.
Lin CH; Chan HY; Chen CC; Chou FH
J Affect Disord; 2022 Dec; 318():386-392. PubMed ID: 36103936
[TBL] [Abstract][Full Text] [Related]
6. Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents.
Dusetzina SB; Weinberger M; Gaynes BN; Farley JF; Sleath B; Hansen RA
Pharmacotherapy; 2012 Dec; 32(12):1085-94. PubMed ID: 23208835
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
Ghaemi SN; Hsu DJ; Thase ME; Wisniewski SR; Nierenberg AA; Miyahara S; Sachs G
Psychiatr Serv; 2006 May; 57(5):660-5. PubMed ID: 16675760
[TBL] [Abstract][Full Text] [Related]
8. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
[TBL] [Abstract][Full Text] [Related]
9. Treatment and outcomes of an Australian cohort of outpatients with bipolar I or schizoaffective disorder over twenty-four months: implications for clinical practice.
Kulkarni J; Filia S; Berk L; Filia K; Dodd S; de Castella A; Brnabic AJ; Lowry AJ; Kelin K; Montgomery W; Fitzgerald PB; Berk M
BMC Psychiatry; 2012 Dec; 12():228. PubMed ID: 23244301
[TBL] [Abstract][Full Text] [Related]
10. Prescribing patterns of antidepressants, antipsychotics and mood stabilizers in bipolar patients misdiagnosed with major depressive disorder in China.
Xiang YT; Hu C; Wang G; Zheng QW; Fang YR; Ungvari GS; Kilbourne AM; Lai KY; Si TM; Chen DF; Lu Z; Yang HC; Hu J; Chen ZY; Huang Y; Sun J; Wang XP; Li HC; Zhang JB; Chiu HF
Hum Psychopharmacol; 2012 Nov; 27(6):626-31. PubMed ID: 23027671
[TBL] [Abstract][Full Text] [Related]
11. Psychopharmacological treatment of non-comorbid and comorbid pervasive developmental disorder and pediatric bipolar disorder.
Hamrin V; McDonnell MA; Moffett J; Durso S
Minerva Pediatr; 2008 Feb; 60(1):87-101. PubMed ID: 18277368
[TBL] [Abstract][Full Text] [Related]
12. Fourteen-year trends in the prescribing patterns of pediatric bipolar patients discharged from two public mental hospitals in Taiwan.
Lin CH; Chan HY; Lin HY; Chen CC
Asia Pac Psychiatry; 2023 Mar; 15(1):e12525. PubMed ID: 36584983
[TBL] [Abstract][Full Text] [Related]
13. Antipsychotic drugs, mood stabilizers, and risk of pneumonia in bipolar disorder: a nationwide case-control study.
Yang SY; Liao YT; Liu HC; Chen WJ; Chen CC; Kuo CJ
J Clin Psychiatry; 2013 Jan; 74(1):e79-86. PubMed ID: 23419234
[TBL] [Abstract][Full Text] [Related]
14. Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study.
Bjørklund L; Horsdal HT; Mors O; Østergaard SD; Gasse C
Acta Neuropsychiatr; 2016 Apr; 28(2):75-84. PubMed ID: 26357986
[TBL] [Abstract][Full Text] [Related]
15. Treatments for late-life bipolar disorder.
Aziz R; Lorberg B; Tampi RR
Am J Geriatr Pharmacother; 2006 Dec; 4(4):347-64. PubMed ID: 17296540
[TBL] [Abstract][Full Text] [Related]
16. Acute inpatient treatment, hospitalization course and direct costs in bipolar patients with intellectual disability.
Wu CS; Desarkar P; Palucka A; Lunsky Y; Liu SK
Res Dev Disabil; 2013 Nov; 34(11):4062-72. PubMed ID: 24051362
[TBL] [Abstract][Full Text] [Related]
17. Current psychotropic medication prescribing patterns in late-life bipolar disorder.
Rej S; Herrmann N; Shulman K; Fischer HD; Fung K; Gruneir A
Int J Geriatr Psychiatry; 2017 Dec; 32(12):1459-1465. PubMed ID: 27911003
[TBL] [Abstract][Full Text] [Related]
18. [Prescribed drug use for bipolar disorder type I and II in clinical practice].
Persson C; Kardell M; Karanti A; Isgren A; Annerbrink K; Landen M
Lakartidningen; 2017 Jan; 114():. PubMed ID: 28094832
[TBL] [Abstract][Full Text] [Related]
19. Pre-diagnostic and post-diagnostic psychopharmacological treatment of 16 288 patients with bipolar disorder.
Köhler-Forsberg O; Gasse C; Hieronymus F; Petersen L; Christensen RH; Nierenberg AA; Østergaard SD
Bipolar Disord; 2021 Jun; 23(4):357-367. PubMed ID: 32648978
[TBL] [Abstract][Full Text] [Related]
20. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.
Bramness JG; Grøholt B; Engeland A; Furu K
J Affect Disord; 2009 Oct; 117(3):208-11. PubMed ID: 19189871
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]